Toward Improved Methodology to Measure the Uptake of Mammography in Populations Using Insurance Claims: A Case Study From Delaware, USA
JCO Clinical Cancer Informatics · 2026-10 · 10 (4)
DOI: 10.1200/cci-26-00065 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2026-10. Verfasst von Neal D Goldstein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, PA. Hauptthemen laut MEDLINE: Mammography, Breast Neoplasms, Early Detection of Cancer, Insurance, Health. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Purpose
Quantifying the uptake of screening mammography at a population level is challenged by suboptimal surveillance data. Insurance claims represent a potentially useful data source; however, claims data can be limited by misclassification. Using a quantitative bias analysis framework, we demonstrate an approach for dealing with imperfect accuracy in an insurance claims database.
Methods
Insurance claims were obtained at the census tract level for screening mammography for the State of Delaware for 2019 and 2022. A measurement model was used to relate the observed uptake of mammography to the true uptake via two approaches: (1) the total number of medical claims and (2) the proportion of government-funded health insurance. Probabilistic Monte Carlo methods yielded a simulation distribution of screening mammograms accounting for misclassification and the associated uncertainty in misclassification parameters.
Results
During the year 2022 and based on the observed measure, the statewide average uptake was 172 mammograms per 1,000 women age 40 and above. This figure increased to a median of 176 mammograms per 1,000 women (95% simulation interval: 173 to 179) using the first adjustment approach and 322 mammograms per 1,000 women (95% simulation interval: 309 to 336) using the second adjustment approach.
Conclusion
When working with administrative data sets for measuring the uptake of screening mammography in a population, researchers and health care administrators should account for potential underreporting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, PA.
- Center for Strategic Information Management, ChristianaCare, Newark, DE.
- Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, PA.
- Data Analytics, Delaware Health Information Network (DHIN), Dover, DE.
- Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, ChristianaCare, Newark, DE.
ORCID-Profile: Neal D Goldstein, Yuchen Zhang, Igor Burstyn, Krishna Vasireddy, Scott D Siegel
Zitieren
APA
Goldstein, N. D., Zhang, Y., Burstyn, I., Vasireddy, K., Garland, D., Enright, M., & Siegel, S. D. (2026). Toward Improved Methodology to Measure the Uptake of Mammography in Populations Using Insurance Claims: A Case Study From Delaware, USA. JCO Clinical Cancer Informatics, 10(4). https://doi.org/10.1200/cci-26-00065
Vancouver
Goldstein ND, Zhang Y, Burstyn I, Vasireddy K, Garland D, Enright M, et al. Toward Improved Methodology to Measure the Uptake of Mammography in Populations Using Insurance Claims: A Case Study From Delaware, USA. JCO Clinical Cancer Informatics. 2026;10(4). doi:10.1200/cci-26-00065
BibTeX
@article{Goldstein2026,
author = {Goldstein, Neal D and Zhang, Yuchen and Burstyn, Igor and Vasireddy, Krishna and Garland, Dawn and Enright, Matt and Siegel, Scott D},
title = {Toward Improved Methodology to Measure the Uptake of Mammography in Populations Using Insurance Claims: A Case Study From Delaware, USA},
journal = {JCO Clinical Cancer Informatics},
year = {2026},
volume = {10},
number = {4},
doi = {10.1200/cci-26-00065}
}
EUVIMED